Artificial pancreas transforming the lives of children and young people with type 1 diabetes
Around 20,000 children and young people with type 1 diabetes in England now benefit from life-changing ‘artificial pancreas’ technology, recommended by the National Institute for Health and Care Excellence (NICE). The innovative hybrid closed loop systems have reached about 3 in 5 eligible children and young people, offering improved blood sugar control and transforming daily life for families managing this complex condition. The NICE recommendation in December 2023 triggered a jump in uptake of hybrid closed loop (HCL) systems from just over one-third to nearly two-thirds in one year. Data from the National Paediatric Diabetes Audit shows that 62% were using HCL systems from April 2024 to March 2025, up from 36% in the same period the previous year.